Andreas Panagopoulos, Katerina Sideri, I. Glenn Cohen et al., Innovation and policy challenges of AI–drug hybrids, 44 Nature Biotechnology 365 (2026).
Abstract: Patent applications indicate a trend toward completely integrating artificial intelligence (AI) with drugs, whereby AI applications will be so tightly linked to drugs that the drugs could be effectively unusable without the AI.